The verified answer
As of Aug 2026, DEPLOY verifies Sentante: 1 model. 1 source back the record.
CategorySurgical robots
Overview
Sentante is a Vilnius-based medical robotics company developing an endovascular robotic platform with haptic force feedback and real-time guidance for remote vascular interventions. The first endovascular robot to complete an entire procedure in a clinical trial (ESSENTIAL, NCT06537947). Backed by €6M seed funding from Practica Capital and EIC Fund.
Verified record
- Verified deployments
- None on file
- Active incidents
- None on file
Key facts
CE Mark
Product
Data & sources
News coverage
1
1 source backing this record.View all →
Models (1)
View all models →Sentante on the deployment map
View the global mapSentante has no verified deployments on the DEPLOY registry yet. Explore the deployment map by place and type.
No verified deployments for Sentante on the DEPLOY record yet. Track Sentante to know the moment the first one is verified.
Safety record
No incidents on record for Sentante.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Recent coverage
Sentante in third-party press
Funding rounds (1)
- Seed2023-12-01
$7M(reported)
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdAug 8, 2026
Added to the verified registry
Sources (1)
Common questions
What is Sentante?
What does Sentante make?
Where is Sentante headquartered?
Where does Sentante operate robots?
Is Sentante a top robotics company?
Is Sentante safe?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-08
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-08
Sources by quality tier
- 1
- secondary-trade-publication
- Trade publication
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Sentante.In the press
Recent coverage mentioning Sentante from third-party publications. Automatically surfaced; not part of the verified registry record.
Sentante launches digital balloon inflation device for endovascular procedures
Sentante has unveiled a new precision-controlled digital indeflator—dubbed ‘Inflante’—that is designed to modernise balloon inflation, improving clinical control and procedural…
Sentante Secures €6 Million in New Funding to Revolutionize Endovascular Care
€6M seed round led by Practica Capital with EIC Fund participation; funds for clinical trial and commercial preparation
Machine-readable surfaces
- Markdown mirror: /companies/sentante.md
- RSS feed: /companies/sentante/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/b01ea9e1-7eb2-41ff-87ea-632d986c63bf
- Revision history: /companies/sentante/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Video
Endovascular robotics for stroke or cardiac or peripheral and more. Deep diving into the haptic feedback world of Sentante Out of Lithuania comes an incredible
Sentante is more than a robotic solution - it’s the key to unlocking the fully digitalized cath lab of the future. By collecting real-time data on force, effort
Meet @Sentante_robot - the future of endovascular interventions🦾 Our fully robotic, teleoperated system offers a range of advantages that are set to transfor
Joe Mullings sits down with Edvardas Satkauskas, CEO of Sentante, to discuss the company’s groundbreaking work in robotic surgery and the future of MedTech.
With Sentante, we’ve created an interface where haptics finally make sense -bringing the feel of manual control into minimally invasive procedures. Sentante isn
Lorenzo Patrone shares his experience using Sentante, offering a brief user testimonial on how the robotic system is used and the value it provides.
Reality vs attention
Sentante draws attention at the 45th percentile but verifies reality at the insufficient-data level among surgical robots.
Analysis
Funding runway warrants monitoring: last known round 33 months ago.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Aug 9, 2026